Importer of Controlled Substances Application: Fisher Clinical Services, Inc., 69070 [2021-26364]

Download as PDF 69070 Federal Register / Vol. 86, No. 231 / Monday, December 6, 2021 / Notices Commission’s statement on adequacy, and any individual Commissioner’s statements will be available from the Office of the Secretary and at the Commission’s website. Authority: These reviews are being conducted under authority of title VII of the Tariff Act of 1930; this notice is published pursuant to § 207.62 of the Commission’s rules. By order of the Commission. Issued: November 30, 2021. Lisa Barton, Secretary to the Commission. [FR Doc. 2021–26341 Filed 12–3–21; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–935] Importer of Controlled Substances Application: Johnson Matthey Inc. Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Johnson Matthey Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 5, 2022. Such persons may also file a written request for a hearing on the application on or before January 5, 2022. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on November 2, 2021, Johnson Matthey Inc., 2003 Nolte Drive, khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 20:32 Dec 03, 2021 Jkt 256001 West Deptford, New Jersey 08066–0727, applied to be registered as an importer of the following basic class(es) of controlled substance(s): Controlled substance Coca Leaves ............................. Thebaine ................................... Opium, raw ............................... Noroxymorphone ...................... Poppy Straw Concentrate ......... Fentanyl .................................... Drug code Schedule 9040 9333 9600 9668 9670 9801 II II II II II II The company plans to import Coca Leaves (9040), Opium raw (9600) and Poppy Straw Concentrate (9670) in order to bulk manufacture Active Pharmaceutical Ingredients (API) for distribution to its customers. The company plans to also import Thebaine (9333), Noroxymorphone (9668) and Fentanyl (9801) to use as analytical reference standards, both internally and to be sold to their customers to support testing of Johnson Matthey Inc.’s API’s only. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of the Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Brian S. Besser, Acting Assistant Administrator. [FR Doc. 2021–26361 Filed 12–3–21; 8:45 am] BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–936] Importer of Controlled Substances Application: Fisher Clinical Services, Inc. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on August 25, 2021, Fisher Clinical Services, Inc., 700A–C Nestle Way, Breinigsville, Pennsylvania 18031–1522, applied to be registered as an importer of the following basic class(es) of controlled substance(s): ADDRESSES: Controlled substance Marihuana Extract ..................... Psilocybin .................................. Methylphenidate ........................ Levorphanol .............................. Noroxymorphone ...................... Tapentadol ................................ Drug code Schedule 7350 7437 1724 9220 9668 9780 I I II II II II The company plans to import the listed controlled substances for use in clinical trials only. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. Drug Enforcement Administration, Justice. ACTION: Notice of application. Brian S. Besser, Acting Assistant Administrator. Fisher Clinical Services, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before January 5, 2022. Such persons may also file a written request for a hearing on the application on or before January 5, 2022. BILLING CODE 4410–09–P AGENCY: SUMMARY: PO 00000 Frm 00069 Fmt 4703 Sfmt 4703 [FR Doc. 2021–26364 Filed 12–3–21; 8:45 am] DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–934] Bulk Manufacturer of Controlled Substances Application: Kinetochem LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: E:\FR\FM\06DEN1.SGM 06DEN1

Agencies

[Federal Register Volume 86, Number 231 (Monday, December 6, 2021)]
[Notices]
[Page 69070]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26364]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-936]


Importer of Controlled Substances Application: Fisher Clinical 
Services, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Fisher Clinical Services, Inc., has applied to be registered 
as an importer of basic class(es) of controlled substance(s). Refer to 
Supplementary Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before January 5, 2022. 
Such persons may also file a written request for a hearing on the 
application on or before January 5, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
request for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on August 25, 2021, Fisher Clinical Services, Inc., 
700A-C Nestle Way, Breinigsville, Pennsylvania 18031-1522, applied to 
be registered as an importer of the following basic class(es) of 
controlled substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Marihuana Extract.......................    7350  I
Psilocybin..............................    7437  I
Methylphenidate.........................    1724  II
Levorphanol.............................    9220  II
Noroxymorphone..........................    9668  II
Tapentadol..............................    9780  II
------------------------------------------------------------------------

    The company plans to import the listed controlled substances for 
use in clinical trials only. No other activity for these drug codes is 
authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2). Authorization will not extend to the import 
of Food and Drug Administration-approved or non-approved finished 
dosage forms for commercial sale.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26364 Filed 12-3-21; 8:45 am]
BILLING CODE 4410-09-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.